Administered by injection, this therapy delivers rapid absorption and sustained benefits, making it a cornerstone of modern wellness and performance medicine
GLP1 receptor agonists approved for treating Type 2 diabetes mellitus and obesity have received attention as a potential antiaddiction treatment
Although extended case studies are still needed to evaluate the adverse effects of aggregated or denatured biomolecules on patients, aggregate formation is still an issue
Ideal candidates typically include: Adults with type 2 diabetes who need improved blood sugar control Individuals with obesity or who are overweight and have struggled to lose weight with diet and exercise alone Patients without the thyroid, pancreatic, gallbladder, or eye conditions described above For these patients, semaglutide, when paired with lifestyle changes like healthy eating and exercise, can be highly effective
How Your Genetics May Influence GLP-1 Response Not everyone responds to GLP-1 medications the same way